These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4971199)
41. The effect of anticholinesterase drugs on postjunctional potentials of skeletal muscle. Skliarov AI Gen Pharmacol; 1980; 11(1):89-95. PubMed ID: 6965920 [No Abstract] [Full Text] [Related]
42. [Studies on muscle relaxants and their antagonists. V. The structure -activity relationship and the mode of action of monoguanidino compounds of frog skeletal muscle]. Ozawa H; Takeda M Yakugaku Zasshi; 1965 Nov; 85(11):991-5. PubMed ID: 5893841 [No Abstract] [Full Text] [Related]
43. [A trisubstituted derivative of orthophosphoric acid possessing powerful anticholinesterase activity]. Olive G; Cheymol G Ann Pharm Fr; 1967 Nov; 25(11):679-82. PubMed ID: 5593164 [No Abstract] [Full Text] [Related]
44. The importance of amino and ester functions for the curarizing activity of quaternary ammonium salts. Verbruggen A; Vanderhaeghe H; Godfraind T Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):171-6. PubMed ID: 999399 [TBL] [Abstract][Full Text] [Related]
45. On the role of the ester groups in the internitrogen chain in the action of bisquaternary compounds on skeletal muscles. Danilov AF; Guli-Kevkhyan RS; Lavrentieva VV; Michelson MJ; Mndjoyan OL; Shelkovnikov SA; Starshinova LA Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):35-51. PubMed ID: 4844369 [No Abstract] [Full Text] [Related]
46. The action of facilitatory drugs and acetylcholine on neuromuscular transmission. Riker WF; Standaert FG Ann N Y Acad Sci; 1966 Jan; 135(1):163-76. PubMed ID: 5221338 [No Abstract] [Full Text] [Related]
47. Effects of halogenoacetylcholines on the neuromuscular junction. Chiou CY Eur J Pharmacol; 1971; 13(3):367-73. PubMed ID: 5577499 [No Abstract] [Full Text] [Related]
48. Ganglion-blocking activity of bisquaternary ammonium salts derived from 3 ,12 -diamino-5 -cholane and 3 ,12 -diamino-24-nor-5 -cholane. Marshall IG; Martin-Smith M Eur J Pharmacol; 1972 Jan; 17(1):39-43. PubMed ID: 4401433 [No Abstract] [Full Text] [Related]
49. The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent. Buckett WR; Marjoribanks CE; Marwick FA; Morton MB Br J Pharmacol Chemother; 1968 Mar; 32(3):671-82. PubMed ID: 4171017 [No Abstract] [Full Text] [Related]
50. The pre-junctional site of action of Enhydrina schistosa venom at the neuromuscular junction. Geh SL; Chan KE Eur J Pharmacol; 1973 Feb; 21(2):115-20. PubMed ID: 4696097 [No Abstract] [Full Text] [Related]
51. [Results of the association of depolarizing and non-depolarizing muscle relaxants]. Foldes FF Anesth Analg (Paris); 1971; 28(5):859-69. PubMed ID: 4258297 [No Abstract] [Full Text] [Related]
52. Mechanism of action of neostigmine at the neuromuscular junction. Webb SN J Pharm Pharmacol; 1971 Dec; 23():227S-228S. PubMed ID: 4401479 [No Abstract] [Full Text] [Related]
53. Multiple mechanisms of action of drugs at the neuromyal junction as studied in the light of the phenomenon of "reversal". Karczmar AG Laval Med; 1967 May; 38(5):465-80. PubMed ID: 5606157 [No Abstract] [Full Text] [Related]
54. [Protection of muscle cholinestarase from irreversible inactivation with armin by means of some miorelaxants]. Shumova IA Farmakol Toksikol; 1968; 31(6):721-5. PubMed ID: 5713587 [No Abstract] [Full Text] [Related]
56. Muscle membrane depolarization by acetylcholine, choline and carbamylcholine, near and remote from motor end-plates. Portela A; Perez RJ; Vaccari J; Perez JC; Stewart P J Pharmacol Exp Ther; 1970 Nov; 175(2):476-82. PubMed ID: 4320452 [No Abstract] [Full Text] [Related]
57. [Curare-like activity of the analogues of diplacin]. Medvedev VA; Mashkovskiĭ MD Farmakol Toksikol; 1968; 31(1):34-6. PubMed ID: 5675344 [No Abstract] [Full Text] [Related]